42
Participants
Start Date
August 31, 2009
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
repaglinide and metformin combination tablet
Combination tablet of repaglinide (1.0 mg)/metformin (500 mg) given just prior to a standard normal breakfast
repaglinide and metformin combination tablet
Combination tablet of repaglinide (2.0 mg)/metformin (500 mg) given just prior to a standard normal breakfast
repaglinide
Co-administration of metformin 500 mg tablet and repaglinide 2 mg tablet given just prior to a standard normal breakfast
metformin
Concomitant administration: Metformin 500 mg tablet and Repaglinide 2 mg tablet
Beijing
Lead Sponsor
Novo Nordisk A/S
INDUSTRY